As reported by Law360 (subscription), a California federal judge has ruled that Johnson & Johnson must pay nearly $344 million in civil penalties for misleading consumers about the true health risks associated with its pelvic mesh products. The trailblazing suit was brought by California’s attorney general, Xavier Becerra, who in a statement touting the judge’s decision said that “J&J knew of the dangers of its mesh products but had prioritized its profits over women’s health.” [Read more…]
The U.S. Food and Drug Administration has ordered Boston Scientific and Coloplast medical device companies to stop selling trans vaginal mesh, also known as pelvic mesh or bladder sling, products used for the transvaginal repair of pelvic organ prolapse and stress urinary incontinence. [Read more…]
Nearly 350 lawsuits included in multidistrict litigation against Boston Scientific Corp. over defective pelvic mesh implants have been settled by a West Virginia federal judge. The case involves seven MDLs composed of 28,000 individual cases against Boston Scientific and other makers of mesh implants, such as American Medical Systems, C.R. Bard Inc., and Johnson & Johnson. [Read more…]
New Zealand has become the first major country to effectively ban surgical mesh implants for all pelvic operations in response to safety concerns and reported mesh hazards. The order from the country’s Ministry of Health is intended to force mesh suppliers to stop marketing the mesh products or prove that they are safe to use. [Read more…]
A New Jersey state appeals court has awarded plaintiff Linda Gross $11.1 million on claims that health care giant Johnson & Johnson’s vaginal mesh product caused serious injuries after use in surgery and that the companies failed to disclose these product risks to physicians and the general public. [Read more…]
Medical device manufacturer Johnson & Johnson (J&J) has agreed to pay a $120 million settlement to the 2-3,000 women who filed injury lawsuits claiming to have suffered organ damage and constant pain from allegedly dangerous and defective surgical mesh. As reported by Bloomberg, these “settlements mark the first time J&J and its Ethicon unit have agreed to resolve a significant number of mesh cases.” [Read more…]
As reported by The Legal Examiner, the U.S. Court of Appeals for the Fourth Circuit upheld the first injury trial jury verdict against transvaginal surgical mesh manufacturer C.R. Bard, a jury award of $2 million in a decision that could affect many thousands of American women allegedly harmed by this medical device known variously as transvaginal mesh (TVM), pelvic mesh, or bladder sling mesh.
The U.S. Food and Drug Administration (FDA) has reclassified the surgical mesh device utilized for transvaginal repair of pelvic organ prolapse (“POP”) and other conditions in women as a high-risk (class III) product. Previously, the agency classified the product as moderate-risk (class II). [Read more…]